Proteomic Analysis of Serum and Urine of HIV-Monoinfected and HIV/HCV-Coinfected Patients Undergoing Long Term Treatment with Nevirapine

Table 3

Peptide intensities of 7 proteins showing differential expression of serum proteins between groups.

Protein	Group 1	Group 2	Group 3	Group 4	Control
RhoBTB3	20.03	0	9.20	0	0
ZTBT44	0	5.49	8.48	16.72	0
Obscurin isoform B	17.40	5.76	3.58	0	28.70
BAI 1	17.30	4.69	1.60	0	28.86
RNA exonuclease 1 homolog	19.05	0	9.10	16.11	29.70
DAPK3	0	7.61	10.61	14.59	30.44
CSPG4	0	6.15	0	12.80	30.66

Group 1: HIV/HCV-coinfected patients with high ALT; Group 2: HIV/HCV-coinfected patients with normal ALT; Group 3: HIV-monoinfected patients with high ALT; Group 4: HIV-monoinfected patients with normal ALT; Control: healthy controls. Seven proteins RhoBTB3: Rho-related BTB domain containing protein 3; ZTBT44: zinc finger and BTB domain containing protein 44; DAPK3: death-associated protein kinase 3; CSPG4: chondroitin sulfate proteoglycan 4. Peptide intensity values are shown to 2 decimal places.